Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial
GSK; PATH (through the Bill & Melinda Gates Foundation and the German Federal Ministry of Education and Research).
Authors
- Kelvin Onoka
- Maame Anima Attobrah Sarfo
- Maame Fremah Kotoh-Mortty
- Evans Antwi
- Aaron M. Samuels (ORCID: https://orcid.org/0000-0002-8355-8186)
- Martina Oneko (ORCID: https://orcid.org/0000-0003-0021-3324)
- Anne Bollaerts
- Cynthia Lee (ORCID: https://orcid.org/0000-0003-2615-7420)
- Robin Fabre
- Ashura Bakari (ORCID: https://orcid.org/0000-0002-2277-2365)
- Cristina Cravcenco
- Yaw Ntiamoah
- Karen Ivinson (ORCID: https://orcid.org/0000-0003-1279-2458)
- Simon Kariuki (ORCID: https://orcid.org/0000-0003-0554-1976)
- Daniel Ansong (ORCID: https://orcid.org/0000-0003-1328-9117)
- Tsiri Agbenyega
- Cecilia Atieno
- Christian F. Ockenhouse
- Nelli Westercamp (ORCID: https://orcid.org/0000-0003-0136-9750)
- François Roman
- Kwame Akoi
- Dennis K Bii
- Lode Schuerman (ORCID: https://orcid.org/0000-0003-0697-6242)
- Lawrence Osei‐Tutu
- Muriel Debois (ORCID: https://orcid.org/0000-0002-3027-2184)
- Samuel Adjei (ORCID: https://orcid.org/0000-0001-5954-908X)
- Opokua Ofori-Anyinam
- Marc Lievens
- Tony Sang
- LS Otieno
- Patrick Boakye Yiadom Buabeng
- Kephas Otieno
- Albert Dornudo Agordo
- Nii Ayi Tagoe
- Kennedy Oduol
Institutions
- Kwame Nkrumah University of Science and Technology (GH)
- Kenya Medical Research Institute (KE)
- Presbyterian University, Ghana (GH)
- GlaxoSmithKline (Belgium) (BE)
Publication Details
- Journal
- The Lancet Global Health
- Published
- 2025-09-17
- DOI
- https://doi.org/10.1016/s2214-109x(25)00272-4
- Citations
- 1
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 1.88